Moeko Iida
Nagoya, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Prognostic Impact of Early GNRI Sustainability in Metastatic Urothelial Carcinoma Receiving Pembrolizumab.
Journal: Anticancer research
Published: January 23, 2026
Integrating pharmacokinetic modeling and wearable-derived physiological data to assess pain intensity in patients with advanced urologic cancer.
Journal: Japanese journal of clinical oncology
Published: October 28, 2025
Cachexia Index Is a Prognostic Indicator in Patients With Metastatic Urothelial Carcinoma Treated With Systemic Chemotherapy.
Journal: Cancer diagnosis & prognosis
Published: March 25, 2024
Evaluation of target area under the concentration-time curve of vancomycin in an initial dosing design: a retrospective cohort study.
Journal: The Journal of antimicrobial chemotherapy
Published: January 22, 2024
Real-world data on efficacy/safety and economic impact of nivolumab administered every 2 and 4 weeks among Japanese patients.
Journal: Asia-Pacific journal of clinical oncology
Published: November 25, 2023
Eosinophil may be a predictor of immune-related adverse events induced by different immune checkpoint inhibitor types: A retrospective multidisciplinary study.
Journal: Cancer medicine
Published: August 28, 2023
Efficacy and safety of combining low-dose methadone with ongoing opioid treatment for uncontrolled cancer pain: an open-label single-arm study.
Journal: The oncologist
Published: May 09, 2023
Development and Evaluation of a Novel Software Program, SAKURA-TDM, for Area Under the Concentration-Time Curve-Guided Vancomycin Dosing: A Short Communication.
Journal: Therapeutic drug monitoring
Published: April 09, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026